SECONDARY ACUTE MYELOID LEUKEMIA
Clinical trials for SECONDARY ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new SECONDARY ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for SECONDARY ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on tough leukemia
Disease control Recruiting nowThis early-stage trial tests a new treatment for acute myeloid leukemia that has returned or not responded to standard therapy. The treatment uses a patient's own immune cells, modified in a lab to recognize and attack leukemia cells. The study aims to find the safest dose and un…
Matched conditions: SECONDARY ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New combo attack on tough blood cancers: chemo plus transplant shows promise
Disease control Recruiting nowThis study tests a new approach for adults with aggressive blood cancers (like AML) that are likely to return after standard treatment. Participants receive a combination of chemotherapy drugs (decitabine plus FLAG-Ida) and low-dose radiation, followed immediately by a stem cell …
Matched conditions: SECONDARY ACUTE MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Immune boosting NK cells aim to stop blood cancer relapse after transplant
Disease control Recruiting nowThis study tests whether giving patients their own personalized natural killer (NK) cells after chemotherapy and a cord blood transplant can help kill leftover cancer cells and reduce the risk of graft-versus-host disease. It includes 100 adults with various blood cancers like le…
Matched conditions: SECONDARY ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New drug cocktail shows promise for tough blood cancers
Disease control Recruiting nowThis study is testing a combination of four chemotherapy drugs (cladribine, idarubicin, cytarabine, and venetoclax) in about 500 people with acute myeloid leukemia, high-risk myelodysplastic syndrome, or a fast-growing form of chronic myeloid leukemia. The goal is to see how well…
Matched conditions: SECONDARY ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 12, 2026 12:03 UTC
-
Could metal detox boost chemo for tough blood cancers?
Disease control Recruiting nowThis early-phase study is testing whether drugs that remove excess metals from the body can help control acute myeloid leukemia (AML) and related blood cancers. Researchers want to see if lowering metal levels in the bone marrow and blood can improve how well chemotherapy works. …
Matched conditions: SECONDARY ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 08, 2026 13:05 UTC